A Prospective, Single Arm, Open Label, Phase II Clinical Study on the Efficacy and Safety of Ivonescimab (AK112) Combined With TAS-102 in the Treatment of Refractory MSS/pMMR Advanced Colorectal Cancer
Clinical trial NCT06936488 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT06936488
- Sponsor
- Huai'an First People's Hospital
- Status
- ENROLLING_BY_INVITATION
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-01
- Primary completion
- 2026-10-31
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.